---
title: "Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292104598.md"
description: "On Wednesday, Prime Medicine emerged victorious in a legal dispute against Beam Therapeutics. Following the court decision, Prime's shares surged, while Beam's stock plummeted. The clash between the two gene editing companies has captured attention, especially since Beam is considered a powerhouse in the industry. The legal battle's outcome has clearly impacted the market, reflected in the contrasting stock movements of Prime and Beam."
datetime: "2026-07-08T18:27:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292104598.md)
  - [en](https://longbridge.com/en/news/292104598.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292104598.md)
---

# Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle

On Wednesday, Prime Medicine emerged victorious in a legal dispute against Beam Therapeutics. Following the court decision, Prime's shares surged, while Beam's stock plummeted. The clash between the two gene editing companies has captured attention, especially since Beam is considered a powerhouse in the industry. The legal battle's outcome has clearly impacted the market, reflected in the contrasting stock movements of Prime and Beam.

### Related Stocks

- [BEAM.US](https://longbridge.com/en/quote/BEAM.US.md)
- [PRME.US](https://longbridge.com/en/quote/PRME.US.md)

## Related News & Research

- [Beam Therapeutics announces press release availability](https://longbridge.com/en/news/293603857.md)
- [Cathie Wood is buying this up-and-coming biotech stock. Should you follow her lead?](https://longbridge.com/en/news/293245844.md)
- [Prime Medicine says FDA clears IND for PM577a in Wilson disease trial](https://longbridge.com/en/news/293661316.md)
- [Innolume orders Veeco Gen2000 MBE system to expand quantum dot laser production](https://longbridge.com/en/news/293555818.md)
- [Siren L.L.C. Buys 2,209,039 Shares of Neumora Therapeutics, Inc. $NMRA](https://longbridge.com/en/news/293740520.md)